Whole-body MRI surveillance in TP53 carriers is perceived as beneficial with no increase in cancer worry regardless of previous cancer: Data from the Swedish TP53 Study

Meis Omran, Hemming Johansson, Claudia Lundgren, Gustav Silander, Marie Stenmark-Askmalm, Niklas Loman, Annika Baan, Jamila Adra, Ekaterina Kuchinskaya, Lennart Blomqvist, Emma Tham, Svetlana Bajalica-Lagercrantz, Yvonne Brandberg, Swedish Clinical TP53 Study Group (SweClinTP53)

Research output: Contribution to journalArticlepeer-review

Abstract

Background: To evaluate the psychosocial consequences of surveillance with whole-body MRI (WB-MRI) in individuals with the heritable TP53-related cancer (hTP53rc) syndrome, also known as the Li-Fraumeni syndrome, with regard to cancer worry, perceived benefits and risks to surveillance and overall health. Patients and methods: Since 2016, the national Swedish TP53 Study (SWEP53) has offered surveillance with WB-MRI to all individuals with hTP53rc syndrome. Seventy-five individuals have been included in the study. Sixty consecutive participants fulfilled a base-line evaluation as well as an evaluation after 1 year with structured questionnaires including the Cancer Worry Scale (CWS), perceived benefits and risks of surveillance, and the 36-item Short Form Survey (SF-36). Individuals with or without previous personal cancer diagnosis were enrolled and results at baseline and after 1 year of surveillance were compared. For SF-36, a comparison with the normal population was also made. Results: Participants with previous cancer tend to worry more about cancer, but both individuals with and without cancer had a positive attitude toward surveillance with no differences regarding perceived benefits and barriers to surveillance. Participants with a previous cancer scored significantly lower on some of the SF-36 subscales, but between-group differences were found only for social functioning after 1 year. Conclusions: Surveillance with WB-MRI is feasible from a psychosocial point of view both among TP53 carriers with as well as without a previous history of cancer and does not increase cancer worry in any of the groups. Plain language summary: Individuals with heritable TP53-related cancer syndrome (also known as the Li-Fraumeni syndrome) have a high lifetime risk of developing cancer. These TP53 carriers are offered surveillance with whole-body MRI to detect cancer early. There are few reports of the psychosocial impact of surveillance. In this study, we wanted to evaluate cancer worry, benefits and barriers to participation, and perceived overall health. Our study shows no increase in cancer worry after 1 year of surveillance, regardless of previous cancer.

Original languageEnglish
Pages (from-to)946-955
JournalCancer
Volume129
Issue number6
Early online date2023
DOIs
Publication statusPublished - 2023

Subject classification (UKÄ)

  • Cancer and Oncology

Free keywords

  • cancer worry scale
  • health-related quality-of-life
  • hereditary cancer
  • heritable TP53-related cancer syndromes
  • Li-Fraumeni syndrome
  • surveillance

Fingerprint

Dive into the research topics of 'Whole-body MRI surveillance in TP53 carriers is perceived as beneficial with no increase in cancer worry regardless of previous cancer: Data from the Swedish TP53 Study'. Together they form a unique fingerprint.

Cite this